<  Retour au portail Polytechnique Montréal

Documents dont l'auteur est "Ghattas, Majed"

Monter d'un niveau
Pour citer ou exporter [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Grouper par: Auteurs ou autrices | Date de publication | Sous-type de document | Aucun groupement
Aller à : G | H | J
Nombre de documents: 6

G

Ghattas, M., Dwivedi, G., Chevrier, A., Scobey, T., El-Mayta, R., Mattocks, M. D., Wang, D., Lavertu, M., & Alameh, M.-G. (2025). Comparative Analysis of Chitosan, Lipid Nanoparticles, and Alum Adjuvants in Recombinant SARS-CoV-2 Vaccine: An Evaluation of Their Immunogenicity and Serological Efficacy. Vaccines, 13(8), 788-788. Lien externe

Ghattas, M., Chevrier, A., Wang, D., Alameh, M.-G., & Lavertu, M. (2025). Reducing endotoxin contamination in chitosan: an optimized purification method for biomedical applications. Carbohydrate Polymer Technologies and Applications, 10, 100797 (9 pages). Disponible

Ghattas, M., Dwivedi, G., Chevrier, A., Horn-Bourque, D., Alameh, M.-G., & Lavertu, M. (2025). Chitosan immunomodulation: insights into mechanisms of action on immune cells and signaling pathways. RSC Advances, 15(2), 896-909. Disponible

Ghattas, M., Dwivedi, G., Lavertu, M., & Alameh, M.-G. (2021). Vaccine Technologies and Platforms for Infectious Diseases: Current Progress, Challenges, and Opportunities. Vaccines, 9(12), 1490 (31 pages). Lien externe

H

Han, X., Alameh, M.-G., Butowska, K., Knox, J. J., Lundgreen, K., Ghattas, M., Gong, N., Xue, L., Xu, Y., Lavertu, M., Bates, P., Xu, J., Nie, G., Zhong, Y., Weissman, D., & Mitchell, M. J. (2023). Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines. Nature Nanotechnology, 18(9), 1105-1114. Lien externe

J

Jeandupeux, E., Alameh, M.-G., Ghattas, M., De Crescenzo, G., & Lavertu, M. (2021). Poly(2-Propylacrylic Acid) Increases In Vitro Bioactivity of Chitosan/mRNA Nanoparticles. Journal of Pharmaceutical Sciences, 110(10), 3439-3449. Lien externe

Liste produite: Fri Dec 5 03:55:49 2025 EST.